期刊文献+

Etiopathogenesis of primary sclerosing cholangitis 被引量:6

Etiopathogenesis of primary sclerosing cholangitis
下载PDF
导出
摘要 Primary sclerosing cholangitis(PSC) is a chronic cholestatic liver disease of unknown etiology but lymphocytic portal tract infiltration is suggestive of an immune-mediated basis for this disease.Associations with inflammatory bowel disease(IBD) especially ulcerative colitis(UC),and with particular autoimmune diseases,as well as the genetic associations further suggest PSC may be an immune-mediated disease.The immunogenetics of PSC have been the subject of active research and several HLA and non-HLA associated genes have been implicated in the development of the disease.Lymphocytes derived from the inflamed gut may enter the liver via the enterohepatic circulation to cause hepatic disease.PSC may be triggered in genetically susceptible individuals by infections or toxins entering the portal circulation through a permeable colon and hence evoking an abnormal immune response. Primary sclerosing cholangitis(PSC) is a chronic cholestatic liver disease of unknown etiology but lymphocytic portal tract infiltration is suggestive of an immune-mediated basis for this disease.Associations with inflammatory bowel disease(IBD) especially ulcerative colitis(UC),and with particular autoimmune diseases,as well as the genetic associations further suggest PSC may be an immune-mediated disease.The immunogenetics of PSC have been the subject of active research and several HLA and non-HLA associated genes have been implicated in the development of the disease.Lymphocytes derived from the inflamed gut may enter the liver via the enterohepatic circulation to cause hepatic disease.PSC may be triggered in genetically susceptible individuals by infections or toxins entering the portal circulation through a permeable colon and hence evoking an abnormal immune response.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第21期3350-3359,共10页 世界胃肠病学杂志(英文版)
关键词 胆管炎 硬化 发病机理 自身抗体 免疫遗传学 Autoantibody Immunogenetics Biliaryepithelial cells T cell receptor Lymphocytes
  • 相关文献

参考文献86

  • 1[1]Worthington J,Cullen S,Chapman R.lmmunopathogenesis of primary sclerosing cholangitis.Clin Rev Allergy Immunol 2005;28:93-103
  • 2[2]Aadland E,Schrumpf E,Fausa O,Elgjo K,Heilo A,Aakhus T,Gjone E.Primary sclerosing cholangitis:a long-term follow-up study.Scand J Gastroenterol 1987;22:655-664
  • 3[3]Broome U,Bergquist A.Primary sclerosing cholangitis,inflammatory bowel disease,and colon cancer.Semin Liver Dis 2006;26:31-41
  • 4[4]Saarinen S,Olerup O,Broome U.Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis.Am J Gastroenterol 2000;95:3195-3199
  • 5[5]Levy C,Lindor KD.Primary sclerosing cholangitis:epidemiology,natural history,and prognosis.Semin Liver Dis 2006;26:22-30
  • 6[6]Terjung B,Worman HJ.Anti-neutrophil antibodies in primary sclerosing cholangitis.Best Pract Res Clin Gastroenterol 2001;15:629-642
  • 7[7]Terjung B,Spengler U,Sauerbruch T,Worman HJ.& quot;Atypical p-ANCA & quot;in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines.Gastroenterology 2000;119:310-322
  • 8[8]Terjung B,Muennich M,Gottwein J,Soehne J.Identification of myeloid-specific tubulin-beta isotype 5 as target antigen of antineutrophil cytoplasmic antibodies in autoimmune liver disease.Hepatology 2005;42:288A
  • 9[9]Mulder AH,Horst G,Haagsma EB,Limburg PC,Kleibeuker JH,Kallenberg CG.Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.Hepatology 1993;17:411-417
  • 10[10]Bansi DS,Bauducci M,Bergqvist A,Boberg K,Broome U,Chapman R,Fleming K,Jorgensen R,Lindor K,Rosina F,Schrumpf E.Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis:a comparison of the alkaline phosphatase and immunofluorescent techniques.Eur J Gastroenterol Hepatol 1997;9:575-580

同被引文献29

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部